Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-24
4:15 pm
Purchase
13GGitLab Inc.
GTLB
GV 2017 L.P.10,822,510
10.8%
639,207increase
(+6.28%)
View
2023-02-10
4:05 pm
Purchase
13GBenson Hill, Inc.
BHIL
GV 2017 L.P.17,849,461
8.7%
3,097,190increase
(+20.99%)
View
2023-02-10
4:05 pm
Purchase
13GGitLab Inc.
GTLB
GV 2017 L.P.10,183,303
10.2%
1,294,527increase
(+14.56%)
View
2023-02-10
4:05 pm
Sale
13GVerve Therapeutics, Inc.
VERV
GV 2017 L.P.10,549,086
17.1%
-424,925decrease
(-3.87%)
View
2022-02-14
5:15 pm
Purchase
13GVerve Therapeutics, Inc.
VERV
GV 2017 L.P.10,974,011
22.78%
10,974,011increase
(New Position)
View
2022-02-14
4:14 pm
Purchase
13GGitLab Inc.
GTLB
GV 2017 L.P.8,888,776
41.36%
8,888,776increase
(New Position)
View
2022-02-14
1:07 pm
Purchase
13GBenson Hill, Inc.
BHIL
GV 2017 L.P.14,752,271
8.29%
14,752,271increase
(New Position)
View
2022-02-14
11:39 am
Purchase
13GTScan Therapeutics, Inc.
TCRX
GV 2017 L.P.1,077,080
5.78%
1,077,080increase
(New Position)
View